MedPath

4D-710

Generic Name
4D-710

4D-710 in Adult Patients With Cystic Fibrosis

Phase 1
Recruiting
Conditions
Cystic Fibrosis Lung
Interventions
First Posted Date
2022-02-21
Last Posted Date
2025-02-21
Lead Sponsor
4D Molecular Therapeutics
Target Recruit Count
40
Registration Number
NCT05248230
Locations
🇺🇸

University of Alabama Child Health Research Unit, Birmingham, Alabama, United States

🇺🇸

University of California San Francisco, San Francisco, California, United States

🇺🇸

National Jewish Health, Denver, Colorado, United States

and more 14 locations
© Copyright 2025. All Rights Reserved by MedPath